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Single cell transcriptomics comes of
age
Sarah Aldridge 1 & Sarah A. Teichmann 1,2✉
Single cell transcriptomics technologies have vast potential in advancing our
understanding of biology and disease. Here, Sarah Aldridge and Sarah Teich-
mann review the last decade of technological advancements in single-cell
transcriptomics and highlight some of the recent discoveries enabled by this
technology.
The past decade has seen a revolution in single-cell transcriptomics. Here we describe advances
made and the transformation that this powerful approach has on our ability to build detailed
cellular maps of tissues, gaining unique insights in health and disease.
Development of single-cell transcriptomics technologies over the past decade
The history of single-cell transcriptomics connects to precursor methods, such as single-cell
qPCR, performed for the first time on a small number of genes by several groups in the early 90 s
(e.g. refs. 1,2). To our knowledge, the first example of bona fide single-cell transcriptomics is the
study of a handful of mouse primordial germ cells by Tang et al. in 20093. While this work was
motivated by the sparsity of very rare cells that arise during murine development, key to driving
forwards single-cell transcriptomics has been the scaling of technologies to profile large numbers
of cells in parallel. The ability to perform unbiased single-cell transcriptome-wide analysis
coupled with exponential scaling in cell numbers that can be analysed simultaneously has almost
followed a “Moore’s Law” of single-cell genomics.
Following Tang et al., other single-cell transcriptomics protocols were developed including tag
sequencing methods such as STRT-seq, and CEL-seq, MARS-seq and full length protocols such
as SMART-seq/SMART-seq2, as well as other methods (Fig. 1). These protocols differed in their
amplification technology and transcript coverage, as well as in the extent of robotisation of liquid
handling in plates. This was followed by development of nanodroplets, picowell technologies and
in situ barcoding which have made it possible to sequence tens of thousands of cells in parallel
(reviewed in ref. 4). In recent years multi-modal single-cell methodologies that measure and
integrate genomics readouts from different molecules (RNA, DNA and protein)5, enabled dis-
section of the complex regulatory and cell-cell communication networks that drive cell identity
to a greater degree than ever before.
Computational methods for low-level processing, quality control and ultimately sophisticated
data interpretation were developed rapidly alongside the first single-cell transcriptomics data
sets6. These methods are crucial for defining cell states and types from data, revealing marker
genes and identifying developmental trajectories that relate cells to each other. The more recent
multi-omics methods are catalysing new computational methods5 as are spatial methods
discussed below.
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Methods for whole transcriptome spatial mapping, character-
isation of gene expression profiles whilst retaining information on
spatial context of expression, are fast emerging. smFISH has been
used for a number of years for analysing gene expression whilst
retaining spatial information in tissue. Methodologies based on
this include low-plex that analyse only a small number of genes in
parallel, up to highly multiplexed that interrogate hundreds or
thousands of mRNA targets in parallel, for example MERFISH,
in situ sequencing, seqFISH, that have emerged over the past five
years or so. Spatial transcriptomics methods, first developed by
Stahl et al., can be used to interrogate the whole transcriptome
coupled with spatial location, with most recent methods begin-
ning to reach single-cell resolution. Combining single-cell tran-
scriptomics with computational and spatial methodologies will
increasingly yield data-rich cell-atlases that map the spatial
location of all cellular gene activities at high resolution.
Single-cell transcriptomics is transforming our understanding
of health and disease
As mentioned above, single-cell transcriptomic approaches were
first applied to model organism, and continue to be instrumental
in driving forwards the understanding of cells and tissues in the
mouse and other organisms such as zebrafish, worm etc. In 2018,
two high-throughput compendia of murine tissues profiled by
single-cell transcriptomics were published (e.g. refs. 7,8). These
compendia provide data across many tissues using relatively
uniform protocols, offering a rich biological resource. Focusing in
on specific organs, a modified version of smFISH (osmFISH) was
used to build an atlas of the mouse brain, giving a detailed view of
cell identifty and exact position within the tissue9.
The scaling of single-cell technologies is ultimately applicable
to the entire human body. Therefore, catalysed by this single-cell
revolution, the Human Cell Atlas (HCA) global consortium was
co-founded in 2016, led by one of us (Sarah Teichmann) and
Aviv Regev (Broad Institute) and including colleagues excited by
the vision. The HCA is using high-throughput technologies at
single-cell resolution to map cells in human tissue, analogous to a
“Google maps” of the human body. The value of high-resolution
transcriptomic data of individual cells in their tissue context is
profound and is generating fundamental knowledge of each
human tissue studied by the HCA community. A healthy refer-
ence atlas of both human tissues and model organisms is a basic
prerequisite to assessing changes in ageing, disease and in
response to therapeutic treatment (Fig. 2).
Examples of new understanding into basic biology from cell
atlasing of human tissues has been highlighted as especially
powerful by studies of human development. The first single-cell
atlas of the maternal-fetal interface in early pregnancy (first tri-
mester placenta and decidua) revealed new cell states (e.g. NK
and stromal cells), and a more detailed cellular and molecular
understanding of the layered architecture of this tissue and its role
in maternal immune tolerance of paternal antigens10. This study
revealed mechanisms behind healthy pregnancy and increases our
understanding of how these could change resulting in conditions
such as pre-eclampsia.
Ground-breaking single-cell-atlases of development have been
further extended to fundamental organs and systems including
for example brain, heart, liver, thymus, gut and kidney. For
example analysing thymic development at single-cell resolution
has deepened understanding of new stromal and epithelial cell
states and novel T cell types and indicates new principles of naïve
T cell V(D)J repertoire formation, revealing that the human naïve
T cell repertoire is biased in its receptor gene segments prior to
pathogen exposure11.
Single-cell transcriptomics have been applied to a spectrum of
diseases including cancer and auto-inflammatory disease. The
airways are a good example of this, where comparison of healthy
and asthmatic lung at single-cell level uncovered novel mucosal
ciliated cell states, and CD4+ T cell states in health (tissue
migratory CD4+ T cell) and disease (pathogenic Th2 cells)12.
This revealed potential new therapeutic targets and provides a
framework for the use of single-cell transcriptomics in target
discovery. Use of scRNA-seq and murine lineage tracing have
been used to analyse the cellular composition of the tracheal
airway, revealing the cystic fibrosis gene CFTR is expressed in a
rare ionocyte cell population at a higher level than in abundant
ciliated cells13. Insights such as these are transforming our
understanding of diseases with genetic components such as cystic
fibrosis and asthma.
In recent months single-cell transcriptomics has been har-
nessed to further our biological understanding of COVID-19
infection in response to the current global pandemic. Single-cell
expression analysis of the coronavirus receptor ACE2, viral entry
associated protease TMPRSS2 and infection associated genes in
healthy human individuals and non-human primates across a
range of tissues gives insights into potential sites of viral trans-
mission. Two specific cell types within the nose look likely to be
sites of infection and could explain high rates of transmission
(reviewed in ref. 14). This provides a valuable platform for
investigating infection, transmission and developing clinical
strategies for prevention and therapy with further single-cell
studies underway.
Future outlook
An exciting area is single-cell transcriptomics for improved
engineering of in vitro cellular models such as organoids. It is
becoming clear that single-cell transcriptomics can be applied
across a breadth of medically important and competitive areas,
including cell-based models, cell therapies, regenerative medicine
and target discovery.
The utility of single-cell transcriptomics for in-depth validation
of organoid models is demonstrated with single-cell RNA-seq
applied to models of the dorsal forebrain, showing reliable reca-
pitulation of the variety of cell types seen in the human cerebral
cortex15. HCA data provides a high-dimensional description of
cell states, including developmental pathways beginning from
early first trimester human embryogenesis. This provides a
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Fig. 1 Development of single-cell technologies. Significant technology developments have enabled the profiling of large numbers of cells in parallel by
single-cell transcriptomics. Initial manual methods allowed single-cell transcriptomic analysis on only a few cells. The development of integrated fluidic
circuits and the introduction of liquid handling robots into the process brought cell numbers to several thousand and then further increased with
nanodroplet and picowell technologies. The introduction of in situ barcoding has increased throughput even further to hundreds of thousands of cells with
the latest developments in spatial methods integrating the spatial location of transcriptomic information within tissue sections.
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precise template for in vitro models, and by comparing in vivo
and in vitro data, we can predict the factors required to generate
improved in vitro systems such as iPSC-derived cells and orga-
noids. Insights from organ cell-atlases, exemplified by the precise
characterisation of CFTR expressing cells in the lung, can be
applied to analysis of gene expression in specific cell types to
inform on the most accurate targeting of gene editing meth-
odologies such as CRISPR-based editing.
As spatial transcriptomic technologies reach single-cell reso-
lution they hold a great deal of promise for study of cells in tissues
with complex morphology, such as regions of the brain and
endometrium. The field is also tackling the challenge of single-cell
spatial transcriptomics of whole organs and this will be hugely
beneficial for the understanding of fundamental processes such as
development. Increasing development of technologies compatible
with FFPE tissue positions these methods as next generation
diagnostic and pathology tools.
The surge of success in single-cell technologies has developed
through the combination of academic research together with
commercial initiatives to make robust, scalable and affordable
technologies. Underpinning this has been the continual devel-
opment of computational methods for data processing, analysis
and integration. Happy tenth birthday single-cell transcriptomics!
May the next decade be even more exciting than the last!
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Fig. 2 Application of single-cell technologies. Single-cell transcriptomics are being used to create reference maps of healthy human tissues, organs and
systems at single-cell resolution. These approaches are also being applied to understand non-human organisms, including mice and non-human primates.
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